Andrew McConaghie (@awmcconaghie) 's Twitter Profile
Andrew McConaghie

@awmcconaghie

Senior Writer, Scrip.
Pharma and healthcare updates

ID: 2340177692

linkhttp://Scrip.pharmaintelligence.informa.com calendar_today12-02-2014 11:23:48

3,3K Tweet

1,1K Followers

4,4K Following

Andrew McConaghie (@awmcconaghie) 's Twitter Profile Photo

FDA tells Sarepta $SRPT it's minded to grant accelerated approval for Duchenne gene therapy, but restricted to 4-5 year olds until Phase 3 results. Will take a little longer than expected - til 22 June - to finish review. shorturl.at/lqJW6